Mesalazine, also known as mesalamine, is a high­ly effec­tive anti-inflam­­ma­­to­ry drug wide­ly used in the treat­ment of inflam­ma­to­ry bow­el dis­eases (IBD), par­tic­u­lar­ly ulcer­a­tive col­i­tis. Derived from 5-aminos­al­i­­cylic acid (5-ASA), mesalazine boasts a well-estab­lished ther­a­peu­tic pro­file, offer­ing tar­get­ed relief and long-term ben­e­fits for patients.

Appli­ca­tions of Mesalazine

Mesalazine serves as the active com­po­nent of sul­fasalazine (SASP), deliv­er­ing the ther­a­peu­tic effects that make it indis­pens­able in man­ag­ing ulcer­a­tive col­i­tis and Crohn’s dis­ease. Its pri­ma­ry mech­a­nism of action involves sup­press­ing inflam­ma­tion in the intesti­nal mucosa by tar­get­ing crit­i­cal inflam­ma­to­ry pathways.

Pri­ma­ry Uses :

  • Treat­ment of Ulcer­a­tive Col­i­tis : Effec­tive­ly alle­vi­ates symp­toms such as abdom­i­nal pain, diar­rhea, and rec­tal bleeding.
  • Main­te­nance of Remis­sion : Helps pre­vent relaps­es in patients with ulcer­a­tive colitis.
  • Man­age­ment of Crohn’s Dis­ease : Used in mild to mod­er­ate cas­es as part of a com­pre­hen­sive treat­ment plan.

Char­ac­ter­is­tics and Advan­tages of Mesalazine

Key Char­ac­ter­is­tics :

  • Tar­get­ed Anti-inflam­­ma­­to­ry Action : Inhibits the syn­the­sis of prostaglandins and the for­ma­tion of leukotrienes, key medi­a­tors of inflammation.
  • Local­ized Deliv­ery : For­mu­lat­ed to deliv­er the active ingre­di­ent direct­ly to the inflamed intesti­nal mucosa for max­i­mum efficacy.
  • Supe­ri­or Safe­ty Pro­file : Min­i­mizes sys­temic side effects, mak­ing it suit­able for long-term use.
  • Proven Clin­i­cal Out­comes : Demon­strates effec­tive­ness in both induc­ing and main­tain­ing remis­sion in patients with ulcer­a­tive colitis.

Core Advan­tages :

  • High Local Effi­ca­cy : Min­i­mal sys­temic absorp­tion ensures pre­cise tar­get­ing of inflammation.
  • Ver­sa­tile For­mu­la­tions : Avail­able as tablets, gran­ules, and rec­tal prepa­ra­tions to meet diverse patient needs.
  • Excel­lent Tol­er­a­bil­i­ty : Suit­able for long-term treat­ment reg­i­mens with min­i­mal adverse effects.

Watson’s Unique Strengths

Wat­son is a trust­ed leader in mesalazine API pro­duc­tion, employ­ing cut­t­ing-edge tech­nol­o­gy and a robust reg­u­la­to­ry frame­work to ensure the con­sis­tent sup­ply of high-qual­i­­ty prod­ucts for glob­al markets.

Reg­u­la­to­ry Approvals :

  • Active­ly pur­su­ing EU Cer­tifi­cate of Suit­abil­i­ty (CEP) and Drug Mas­ter File (DMF) reg­is­tra­tion in Japan.

Oper­a­tional Excel­lence :

  • Strin­gent Qual­i­ty Stan­dards : Adheres to inter­na­tion­al bench­marks, ensur­ing con­sis­tent prod­uct performance.
  • Glob­al Export Capa­bil­i­ties : Sup­plies mesalazine to strin­gent reg­u­la­to­ry mar­kets, includ­ing Europe and Japan.
  • Reg­u­la­to­ry Sup­port : Pro­vides com­pre­hen­sive doc­u­men­ta­tion and assis­tance to stream­line mar­ket entry for phar­ma­ceu­ti­cal manufacturers.

Watson’s Mar­ket Competitiveness

Reli­able Sup­ply Chain :

  • Advanced Man­u­fac­tur­ing Facil­i­ties : State-of-the-art facil­i­ties ensure effi­cient pro­duc­tion and con­sis­tent quality.
  • Effi­cient Logis­tics : A robust net­work ensures unin­ter­rupt­ed sup­ply to part­ners worldwide.

Cus­­tomer-Cen­tric Approach :

  • Cus­tomiza­tion : Offers tai­lored solu­tions, includ­ing spe­cif­ic par­ti­cle sizes and for­mu­la­tions, to meet diverse cus­tomer needs.

Com­pet­i­tive Pric­ing :

Com­bines pre­mi­um qual­i­ty with cost-effec­­tive solu­tions, ensur­ing excep­tion­al val­ue for partners.

Sales Link

Mesalazine on Watson